BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9301676)

  • 1. Synthesis and pharmacological characterization of aminocyclopentanetricarboxylic acids: new tools to discriminate between metabotropic glutamate receptor subtypes.
    Acher FC; Tellier FJ; Azerad R; Brabet IN; Fagni L; Pin JP
    J Med Chem; 1997 Sep; 40(19):3119-29. PubMed ID: 9301676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
    Konieczny J; Wardas J; Kuter K; Pilc A; Ossowska K
    Neuroscience; 2007 Mar; 145(2):611-20. PubMed ID: 17224239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of the four isomers of 4-aminopyrrolidine-2,4-dicarboxylate: identification of a potent, highly selective, and systemically-active agonist for metabotropic glutamate receptors negatively coupled to adenylate cyclase.
    Monn JA; Valli MJ; Johnson BG; Salhoff CR; Wright RA; Howe T; Bond A; Lodge D; Spangle LA; Paschal JW; Campbell JB; Griffey K; Tizzano JP; Schoepp DD
    J Med Chem; 1996 Jul; 39(15):2990-3000. PubMed ID: 8709133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats.
    Tatarczyńska E; Pałucha A; Szewczyk B; Chojnacka-Wójcik E; Wierońska J; Pilc A
    Pol J Pharmacol; 2002; 54(6):707-10. PubMed ID: 12866729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actions of LY341495 on metabotropic glutamate receptor-mediated responses in the neonatal rat spinal cord.
    Howson PA; Jane DE
    Br J Pharmacol; 2003 May; 139(1):147-55. PubMed ID: 12746233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 2. Effects of aromatic substitution, pharmacological characterization, and bioavailability.
    Ornstein PL; Bleisch TJ; Arnold MB; Kennedy JH; Wright RA; Johnson BG; Tizzano JP; Helton DR; Kallman MJ; Schoepp DD; Hérin M
    J Med Chem; 1998 Jan; 41(3):358-78. PubMed ID: 9464367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of transmitter release by high-affinity group III mGluRs in the supraoptic nucleus of the rat hypothalamus.
    Panatier A; Poulain DA; Oliet SH
    Neuropharmacology; 2004 Sep; 47(3):333-41. PubMed ID: 15275822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
    Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.
    Gasparini F; Bruno V; Battaglia G; Lukic S; Leonhardt T; Inderbitzin W; Laurie D; Sommer B; Varney MA; Hess SD; Johnson EC; Kuhn R; Urwyler S; Sauer D; Portet C; Schmutz M; Nicoletti F; Flor PJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1678-87. PubMed ID: 10336568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Alkylated homoibotenic acid (HIBO) analogues: versatile pharmacological agents with diverse selectivity profiles towards metabotropic and ionotropic glutamate receptor subtypes.
    Madsen U; Pickering DS; Nielsen B; Bräuner-Osborne H
    Neuropharmacology; 2005; 49 Suppl 1():114-9. PubMed ID: 15996690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems.
    Stachowicz K; Kłodzińska A; Palucha-Poniewiera A; Schann S; Neuville P; Pilc A
    Neuropharmacology; 2009 Sep; 57(3):227-34. PubMed ID: 19539634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent.
    Stachowicz K; Chojnacka-Wójcik E; Kłak K; Pilc A
    Neuropharmacology; 2007 Feb; 52(2):306-12. PubMed ID: 17020774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Aminocyclopentane-1,2,4-tricarboxylic acids screening on glutamatergic and serotonergic systems.
    Gelmi ML; Caputo F; Clerici F; Pellegrino S; Giannaccini G; Betti L; Fabbrini L; Schmid L; Palego L; Lucacchini A
    Bioorg Med Chem; 2007 Dec; 15(24):7581-9. PubMed ID: 17900912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group III mGlu receptor agonist, ACPT-I, exerts potential neuroprotective effects in vitro and in vivo.
    Domin H; Gołembiowska K; Jantas D; Kamińska K; Zięba B; Smiałowska M
    Neurotox Res; 2014 Jul; 26(1):99-113. PubMed ID: 24402869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of phosphoinositide turnover in neonatal rat cerebral cortex by group I- and II- selective metabotropic glutamate receptor agonists.
    Mistry R; Golding N; Challiss RA
    Br J Pharmacol; 1998 Feb; 123(3):581-9. PubMed ID: 9504400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclobutane quisqualic acid analogues as selective mGluR5a metabotropic glutamic acid receptor ligands.
    Littman L; Tokar C; Venkatraman S; Roon RJ; Koerner JF; Robinson MB; Johnson RL
    J Med Chem; 1999 May; 42(9):1639-47. PubMed ID: 10229632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Substituted (2SR)-2-amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as potent and selective antagonists of group II metabotropic glutamate receptors. 1. Effects of alkyl, arylalkyl, and diarylalkyl substitution.
    Ornstein PL; Bleisch TJ; Arnold MB; Wright RA; Johnson BG; Schoepp DD
    J Med Chem; 1998 Jan; 41(3):346-57. PubMed ID: 9464366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of metabotropic glutamate receptor-mediated high-affinity GTPase activity in rat cerebral cortical membranes.
    Nishi N; Odagaki Y; Koyama T
    Br J Pharmacol; 2000 Aug; 130(7):1664-70. PubMed ID: 10928972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunocytochemical and pharmacological characterization of metabotropic glutamate receptors of the vestibular end organs in the frog.
    Andrianov GN; Puyal J; Raymond J; Ventéo S; Demêmes D; Ryzhova IV
    Hear Res; 2005 Jun; 204(1-2):200-9. PubMed ID: 15925205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of 1-amino-2-phosphonomethylcyclopropanecarboxylic acids, new group III metabotropic glutamate receptor agonists.
    Sibille P; Lopez S; Brabet I; Valenti O; Oueslati N; Gaven F; Goudet C; Bertrand HO; Neyton J; Marino MJ; Amalric M; Pin JP; Acher FC
    J Med Chem; 2007 Jul; 50(15):3585-95. PubMed ID: 17602546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.